New Market Research Report: Global Insomnia Market - Market Research Analysis 2015-2019

Insomnia or sleeplessness is characterized by the difficulty in falling asleep or remaining asleep, resulting in poor quality of sleep or little sleep. Sleeplessness can be acute or chronic. Work-related stress is the more common factor for acute or primary insomnia, while medical conditions, such as arthritis, or medicines, such as amphetamines, and substances, such as cocaine, are the common factors for chronic insomnia.

Technavio's analysts forecast the global insomnia market to decline at a CAGR of 3.08% over the period 2014-2019.

Full Report Details at
- http://www.fastmr.com/prod/1052828_global_insomnia_market.aspx?afid=301

Covered in this report
The report includes the present scenario and the growth prospects of the global insomnia market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of insomnia.

Technavio's report, Global Insomnia Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.

Key regions

* Americas
* APAC
* EMEA

Key vendors

* Eisai
* Merck
* Pfizer
* Sanofi
* Takeda

Other prominent vendors

* Astellas
* Biocodex
* Dainippon Sumitomo
* ECR Pharmaceuticals (Valeant)
* Fidia Farmaceutici
* Flynn Pharma
* Johnson & Johnson
* Juste
* Meda

Key market driver

* Unmet medical needs
* For a full, detailed list, view our report

Key market challenge

* Dominance of generic products
* For a full, detailed list, view our report

Key market trend

* Emerging drugs targeting orexin receptors
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2019 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?
* What are the market opportunities and threats faced by the key vendors?
* What are the strengths and weaknesses of the key vendors?

Companies Mentioned in this Report: Eisai, Merck, Pfizer, Sanofi, Takeda, Astellas, Biocodex, ECR Pharmaceuticals, Dainippon Sumitomo, Fidia Farmaceutici, Flynn Pharma, Johnson & Johnson, Juste, Meda, Medice Arzneimittel Putter, Minerva Neurosciences, Neurim, Pernix Therapeutics, Purdue Pharma, SkyePharma, Somnus Therapeutics, Paratek Pharmaceuticals, Vanda Pharmaceuticals

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- PharmaPoint: Insomnia - Global Drug Forecast and Market Analysis to 2023
- Insomnia - Pipeline Review, H2 2014
- PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023
- Surface Analysis Market - Global Forecast to 2020
- Autonomous Underwater Vehicles (AUV) Market - Analysis & Forecast to 2020